ANZUP1802
21 Dec 2020
UNICAB
NCT03685448
ANZUP – Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)
ANZUP
Cancer Type | Kidney |
---|---|
Trial Type | Treatment |
Phase | Phase II |
Age Range | 18 years and older |
Sex | Both |
Tumour Stream | - |
Cancer Stage | Locally Recurrent or Locally Advanced, Metastatic or Widespread |
Anticipated Start Date | 2019-04-11 |
Anticipated End Date | - |
Hospital | Flinders Medical Centre |
---|---|
Clinical Trial Coordinator | Alex Scott-Hoy |
alex.scott-hoy@sa.gov.au | |
Phone | 08 8204 4830 |
Principal Investigator | Dr Ganessan Kichenadasse |
Recruitment Status | Recruiting |
Hospital | Ashford Cancer Centre Research |
---|---|
Clinical Trial Coordinator | Sue Yeend |
syeend@adelaidecancercentre.com.au | |
Phone | 08 8292 2240 |
Principal Investigator | - |
Recruitment Status | Recruitment on Hold |